Most sleep aids carry real risks when used regularly, though the severity depends on the type. Over-the-counter antihistamines, prescription sedatives, and melatonin supplements each come with a distinct set of trade-offs. Occasional use of any of them is unlikely to cause lasting harm for most people, but routine nightly use is where problems start to accumulate.
OTC Antihistamines: The Hidden Downsides
The most popular over-the-counter sleep aids, sold under brands like ZzzQuil, Unisom SleepTabs, and generic “PM” pain relievers, contain either diphenhydramine or doxylamine. Both are antihistamines that work by blocking a chemical messenger called acetylcholine, which plays a key role in learning, memory, and muscle function. That’s why they make you drowsy, but it’s also why the side effects go well beyond sleepiness.
Short-term memory problems, mental fog, dry mouth, constipation, and difficulty urinating are all common. These effects hit older adults especially hard, increasing confusion and the risk of falls. What concerns researchers more is the long-term picture: a 10-year prospective study found that regular sleep medication use was associated with a 30% increased risk of developing dementia, even after adjusting for other factors. That finding doesn’t prove causation, but it’s consistent with what scientists know about how blocking acetylcholine affects the brain over time.
Your body also adjusts to antihistamines quickly. Many people notice the drowsiness effect weakening after just a week or two of nightly use, which can lead to taking higher doses for the same result.
Prescription Sleep Medications
Prescription options like zolpidem (Ambien), eszopiclone (Lunesta), and zaleplon belong to a class often called Z-drugs. They target the same brain receptors as older sedatives but were originally marketed as safer alternatives. That turned out to be only partly true.
The FDA has received reports of people on these medications sleepwalking, sleep-driving, cooking while asleep, and even accidentally shooting themselves or wandering outside in freezing temperatures. These complex sleep behaviors can happen after a single dose or after months of use, and they occur at low doses, not just high ones. People typically have no memory of these events the next morning.
For adults over 65, the fracture risk is significant. A meta-analysis combining data from multiple studies found that older adults taking Z-drugs had roughly 63% higher odds of fracturing a bone compared to those not taking the drugs. In some study designs, the risk was even higher, more than doubling the odds of fracture.
Tolerance and Rebound Insomnia
Tolerance to the sleep-inducing effects of sedatives develops fast. With benzodiazepine-type drugs, sleep recordings show that sleep patterns often return to pre-treatment levels within a few weeks. At that point, you’re taking the drug mainly to avoid withdrawal rather than to gain any real benefit. Daytime anxiety users of the same drug class stop feeling drowsy after just a few days, which illustrates how rapidly the brain compensates.
Stopping abruptly can trigger rebound insomnia, where your sleep becomes temporarily worse than it was before you started the medication. This typically lasts one to two nights with shorter-acting drugs, but the experience is jarring enough that many people interpret it as proof they “need” the medication and restart it. That cycle is one of the main ways long-term dependence develops.
Melatonin: Safer but Not Risk-Free
Melatonin is fundamentally different from the drugs above. It’s a hormone your brain already produces to signal that it’s time for sleep, and supplementing it doesn’t carry the same dependence risks. Unlike antihistamines and sedatives, you’re unlikely to build tolerance to melatonin or experience withdrawal when you stop.
Side effects are generally mild: headaches, dizziness, nausea, and occasionally vivid dreams or nightmares. The bigger concern is what’s actually in the bottle. A study published by researchers and highlighted by the American Academy of Sleep Medicine tested a range of melatonin supplements and found that more than 71% of them didn’t contain the amount listed on the label, even within a generous 10% margin. Actual melatonin content ranged from 83% less than advertised to 478% more. Even different batches of the same product varied by as much as 465%. Because melatonin is classified as a supplement rather than a drug, it doesn’t go through the same quality controls as pharmaceuticals.
Long-term safety data on melatonin is still limited. Short-term use appears safe for most adults, but researchers haven’t yet established what years of nightly supplementation does to your body’s own melatonin production or other hormonal systems.
Sleep Apnea: A Special Warning
If you snore heavily or have been told you stop breathing during sleep, sedative sleep aids pose an additional danger. Drugs that relax the central nervous system, including benzodiazepines and opioids, can suppress your breathing drive, making apnea episodes longer and more dangerous. Even over-the-counter options that cause deep sedation can make it harder for your body to wake itself up when airflow is blocked.
Prescription sleep aids like zolpidem and eszopiclone are considered relatively safe for people with sleep apnea only if the apnea is already being treated with a CPAP machine or similar device. Without that treatment in place, adding a sedative to undiagnosed or untreated sleep apnea is a risky combination.
What Works Better for Chronic Insomnia
The American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) as the most effective first-line treatment for ongoing sleep problems. It’s a structured program, typically lasting four to eight weeks, that addresses the habits, thought patterns, and sleep environment issues that keep insomnia going. Unlike medication, the improvements tend to last after treatment ends.
CBT-I includes techniques like sleep restriction (temporarily limiting time in bed to build stronger sleep pressure), stimulus control (retraining your brain to associate the bed with sleep rather than wakefulness), and restructuring anxious thoughts about sleep. It can be delivered in person, through telehealth, or even through validated apps.
Adding medication to CBT-I can modestly improve total sleep time for some people, but the AASM’s guideline specifically recommends against choosing medication alone over CBT-I. Behavioral treatment by itself produces meaningful, durable improvements without the risks that come with pharmacotherapy. In other words, sleep aids can serve as a short-term bridge, but they’re a poor long-term strategy for most people with chronic insomnia.